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1  | INTRODUC TION
Carbon monoxide (CO) is the leading cause of injury and death by 
poisoning worldwide,1,2 with approximately 50 000 emergency 
admissions in the United States alone each year.3 Deaths from 
CO poisoning are usually intentional or accidentally caused.3 CO 
forms during incomplete combustion of organic materials. Typical 
sources of intoxication are smoke from fires, indoor charcoal burn-
ing, exhaust from combustion engines and faulty residential heat-
ing systems.4 Exposure is particularly insidious, as CO is a tasteless, 
odourless, colourless and non- irritant gas, often undetectable by 
human senses.1 Signs and symptoms of CO toxicity include head-
ache, nausea, dizziness, confusion, chest pain, palpitation, tachycar-
dia, cardiac dysrhythmias, cardiac and respiratory arrest, pulmonary 
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Abstract
Carbon monoxide (CO) is the leading cause of death by poisoning worldwide. The 
aim was to explore the effects of mild and severe poisoning on blood gas parameters 
and metabolites. Eleven pigs were exposed to CO intoxication and had blood col-
lected before and during poisoning. Mild CO poisoning (carboxyhaemoglobin, COHb 
35.2 ± 7.9%) was achieved at 32 ± 13 minutes, and severe poisoning (69.3 ± 10.2% 
COHb) at 64 ± 23 minutes from baseline (2.9 ± 0.5% COHb). Blood gas parameters 
and metabolites were measured on a blood gas analyser and nuclear magnetic res-
onance spectrometer, respectively. Unsupervised principal component, analysis of 
variance and Pearson's correlation tests were applied. A P- value ≤ .05 was consid-
ered statistically significant. Mild poisoning resulted in a 28.4% drop in oxyhaemo-
globin (OHb) and 12- fold increase in COHb, while severe poisoning in a 65% drop in 
OHb and 24- fold increase in COHb. Among others, metabolites implicated in regula-
tion of metabolic acidosis (lactate, P < .0001), energy balance (pyruvate, P < .0001; 
3- hydroxybutyrc acid, P = .01), respiration (citrate, P = .007; succinate, P = .0003; 
fumarate, P < .0001), lipid metabolism (glycerol, P = .002; choline, P = .0002) and 
antioxidant- oxidant balance (glutathione, P = .03; hypoxanthine, P < .0001) were al-
tered, especially during severe poisoning. Our study adds new insights into the de-
ranged metabolism of CO poisoning and leads the way for further investigation.
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oedema, unconsciousness and coma.5 If patients survive, neurologi-
cal sequelae can appear.1
When poisoning is suspected, measurement of blood carboxy-
haemoglobin (COHb) is performed.6,7 Normal blood COHb levels 
range between 1% and 3%; however, up to 10% has been detected 
in active smokers.8 Mild signs and symptoms of toxicity can be pres-
ent at COHb levels ranging from 3% to 24%,5,6 while loss of con-
sciousness normally occurs at levels above 24%, and exposure to 
higher levels has been shown to be fatal.1,6 The treatment of CO 
poisoning consists of O2 therapies. While oxygen can be adminis-
tered at normal pressure, normobaric oxygen therapy or as hyper-
baric oxygen therapy, current evidence shows that treatment does 
not necessarily influence patient outcome.9,10 Also, although COHb 
is the gold diagnostic standard, it is a poor predictor of the severity 
of acute toxicity. For example, studies have shown that the relation-
ship between COHb levels and the severity of clinical symptoms is 
not well correlated because of the time between exposure cessation 
and the effects of supplemental oxygen treatments prior to COHb 
measurements.6,7
In order to improve evaluation of the severity of CO intoxication, 
focus is needed on understanding the molecular mechanisms in-
volved in its progression.9,10 Under physiological conditions, endog-
enously produced CO is involved in cellular regulation of numerous 
physiological systems, including brain and muscle oxygen storage and 
utilization, relaxation of vascular and extra- vascular smooth muscle, 
modulation of synaptic neurotransmission, and anti- inflammatory, 
- apoptotic, anti- proliferative and anti- thrombotic processes. During 
exposure to abnormal exogenous CO levels, however, these physio-
logical mechanisms are disrupted. Inhaled CO diffuses rapidly across 
the alveolar- capillary membrane and becomes excessively absorbed 
into blood and subsequently distributed throughout the body. The 
distribution of CO in the body is reflected by the binding of CO 
to haeme proteins (eg blood haemoglobin and tissue myoglobin). 
Approximately 80%- 90% of the absorbed CO binds to haemoglo-
bin (Hb) with a 200- fold greater affinity than that of oxygen (O2), 
forming COHb, which in turn, reduces blood oxygen- carrying capac-
ity and induces impaired perfusion and tissue hypoxia.1 Although 
all tissues are vulnerable to CO- induced hypoxic injury, the brain, 
heart and lungs are particularly vulnerable, because of their high O2 
demands. Some of the remaining CO binds to tissue myoglobin and 
neuroglobin, affecting brain and muscle oxygen storage and utiliza-
tion. Although the molecular mechanisms of poisoning are not fully 
elucidated, evidence indicates that these events lead to derange-
ments in ion channels, inactivation of mitochondrial enzymes, im-
mune system activation, DNA damage and cell death.1,2,5,9,11– 16
Until now, very few studies have investigated the effect of CO poi-
soning on the metabolome.17,18 In a pilot metabolomics study, Ju et al17 
investigated blood metabolites from deceased patients because of poi-
soning and found altered fatty acid metabolism. While this study added 
new insights to the deranged mechanisms of CO poisoning, it was per-
formed post- mortem. Hence, acute metabolite alterations reflecting on-
going toxicity may not have been reflected, because of the time elapsed 
from exposure cessation to sample collection. We have previously 
applied metabolomics to identify altered mechanisms in ischaemia- 
reperfusion injury,19– 22 hyperoxia23 and the progression to acute lung 
injury.20,24,25 Therefore, in this current experimental study, we have 
been suggested that metabolomics can be used to detect metabolite 
changes related to the progression of acute CO poisoning. The aim was 
to explore the effects of mild and severe CO poisoning on arterial blood 
gas parameters and to associate potential metabolite alterations to in-
creasing COHb levels. Because of the anatomical and immunological 
similarities between the porcine and human models,26 pigs were used in 
this study and arterial blood samples were collected before and during 
exposure to exogenous CO.
2  | MATERIAL S AND METHODS
2.1 | Ethics regarding use of research animals
These experiments were approved by the Danish Animal 
Experiments Inspectorate (J.nr 2016- 15- 0201- 01064) and were car-
ried out in accordance with research animal legislation. The experi-
ments were performed at the Biomedical Research Laboratory at 
Aalborg University Hospital under the supervision of a veterinarian. 
At the end of the study, the pigs were sacrificed by an overdose of 
Pentobarbital.
2.2 | Experimental animals and instrumentation
A total of eleven Danish Landrace female pigs (mean ± standard de-
viation, SD; 48.4 ± 2.46 kg) were included in this study. The animals 
were initially anaesthetized using Zoletil (Tiletamine/Zolazepam) 
and once intravenous access was established, anaesthesia was 
continued with an intravenous infusion of Fentanyl and Propofol. 
Intubation was performed by insertion of a 6.5 mm tube. The ven-
tilator (Dameca DREAM) was set to a tidal volume equivalent of 
8 mL/kg bodyweight, positive end- expiratory pressure of 5 cm H2O 
and fraction of inspired oxygen (FiO2) to the lowest value needed 
to ensure an arterial partial pressure of oxygen (PaO2) in the normal 
range of 9.6- 13.7 kPa. Ventilation was set at a rate ensuring normal 
end- tidal CO2 (ETCO2) values between 4.7 and 6.0 kPa. Published 
guidelines for fluid therapy were used.26,27 The pigs' vital signs were 
monitored during the experiment; urine production and tempera-
ture with a thermo- catheter inserted into the bladder, continuous 
electrocardiography (Zoll Pro Pac MD, ZOLL Medical Corporation), 
and arterial blood pressure through an arterial catheter inserted into 
the carotid artery. Arterial blood gas values along with glucose, lac-
tate, pH, COHb and OHb were recorded frequently (ABL825 FLEX 
Series, Radiometer Medical).
The ventilator was connected to the pig together with a pres-
sure cylinder containing pure CO and a closed loop connected to the 
CO- monitor (Exhaust Emission Gas Analyser, Model SV- 5Q). CO was 
delivered with a pressure reduction valve and connected to the CO- 
monitor and via the ventilator to the pig, forming a closed system to 
     |  5193SIMONSEN Et al.
avoid leakage of CO into the laboratory room. When administering 
CO, the valve was opened intermittently, to avoid overdosing and to 
keep the maximum inhaled concentration around 1%- 2%. Constant 
CO- monitoring with an alarm was used in the room to ensure safety 
of the laboratory personnel. The experimental setup is shown in 
Figure 1.
2.3 | Experimental protocol
Blood samples for metabolite measurements were drawn at baseline 
and during exposure to CO, but precisely 10 minutes after inhala-
tion of CO. The delay was to allow dispersion of CO throughout the 
body until COHb values indicated mild poisoning, defined as ~30% 
COHb, and severe poisoning, defined as >60% COHb and the point 
of cardiac failure. Cardiac failure was defined as a 50% decrease 
in cardiac output compared to baseline. This was measured using 
ultrasonography. Blood was collected in sterile BD Vacutainer® 
tubes of 10 mL containing clot activator factor. Samples were left 
at room temperature for 30 minutes and centrifuged at 2000 g for 
10 minutes and 4°C. Serum was obtained and stored at −80°C until 
analysed.
Samples were thawed for 30 minutes at 4°C and centrifuged 
for 5 minutes at 4°C and 12 100 g. Aliquots of 400 μL of super-
natant were mixed with 200 μL D2O phosphate buffer (0.2 mol/L 
Na2HPO4/NaH2PO4, pH = 7.4, in 99% 
2H2O). Throughout the whole 
procedure, samples were kept on ice. Samples were transferred to 
a 5 mm NMR tube and 1H- NMR spectra were recorded at a tem-
perature of 25°C using a T2- filtered one- dimensional Carr- Purcell- 
Meiboom- Gill (CPMG) pulse sequence with water suppression, as 
F I G U R E  1   Experimental diagram 
showing the flow of air and CO in 
the experimental setup (arrows). CO, 
carbon monoxide; Insp, inspiration; Exp, 






















TA B L E  1   Arterial blood gas measurements obtain from arterial blood collected from eleven Danish Landrace pigs before, and during mild 
and severe poisoning
Baseline
(COHb 2.9 ± 0.5%)
Mild










Mean SD Mean SD Mean SD P- value P- value P- value
pH 7.40 0.05 7.40 0.07 7.30 0.09 .002 1.00 .007
PaCO2 (kPa) 5.48 0.37 5.46 0.52 5.29 0.91 .67 .99 .69
PaO2 (kPa) 11.1 2.5 10.5 4.5 4.56 1.96 .000004 .78 .00001
COHb (%) 2.9 0.5 35.2 7.9 69.3 10.2 <.000001 <.000001 <.000001
OHb (%) 91.2 4.9 62.8 10.2 26.2 8.2 <.000001 .0004 <.000001
Glucose (mmol/L) 4.9 1.5 5.2 1.9 6.5 5.0 .93 .98 .92
Lactate (mmol/L) 1.4 0.4 1.7 1.0 6.3 1.7 <.000001 .25 <.000001
Note: Significance was assessed by means of ANOVA (a) with Tukey's post hoc test for multiple testing (b). A two- tailed P- value ≤ .05 was considered 
statistically significant.
Abbreviations: COHb, carboxyhaemoglobin; OHb, oxyhaemoglobin; PaCO2, partial pressure of carbon dioxide; PaO2, partial pressure of oxygen; SD, 
standard deviation.
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previously described.19– 21,25 Spectral acquisition was controlled 
using the TopSpin 3.1 software (Bruker BioSpin).
2.4 | Data analysis
Spectral processing, metabolite identification and quantification 
were performed as previously described.20,21,25 Multivariate data 
analysis was performed using the PLS Toolbox 6.5 (Eigenvector 
Research) in MATLAB (R2017a, MathWork) and the statistical 
analyses in the IBM® SPSS Statistics software (v. 24, SPSS Inc). 
Unsupervised principal component analysis (PCA) was carried out to 
identify possible outliers and trends in the data. Data were visualized 
by plotting the scores of the first two principal components (PC1 
and PC2), encompassing the largest variation. Metabolite quantifica-
tion was performed in AMIX (Analysis of MIXtures v. 3.9.10, Bruker 
BioSpin) using the sum of all points under each peak of interest.
To determine differences between metabolite levels from 
samples collected at baseline and during mild and severe CO poi-
soning, standard biostatistical tests were applied.19– 25 We first 
employed a Shapiro- Wilk test to verify whether the data followed 
a normal distribution. Differences in group means were assessed 
by using analysis of variance (ANOVA) with Tukey's post hoc for 
multiple testing on logarithmically transformed data. Pearson cor-
relation was applied to test the association of COHb levels and 
duration of exposure to CO with blood gas parameters and me-
tabolites. A two- tailed P- value ≤ .05 was considered statistically 
significant.
Scatter and box- plots were used to visualize molecular changes 
from before and during poisoning. Relative concentrations are pre-
sented using means and standard deviations (SD). The quality of 
NMR data was assessed by correlating levels of fresh arterial blood 
glucose and lactate recorded on the ABL800 to serum glucose and 
lactate measured by NMR.
3  | RESULTS
3.1 | Determination of CO poisoning
Carboxyhaemoglobin levels were measured in arterial blood collected 
from eleven Danish Landrace pigs at different time points before and 
during exposure to CO. To facilitate proper comparison, only blood 
gas data obtained from the samples used for metabolomics analy-
ses are presented (Table 1). The measured COHb was 2.9 ± 0.5% at 
baseline, 35.2 ± 7.9% at mild poisoning and 69.3 ± 10.2% at severe 
poisoning. Mild CO poisoning was achieved after 32 ± 13 minutes, 
while severe poisoning occurred at 64 ± 23 minutes from baseline.
Increased COHb and decreased oxyhaemoglobin (OHb) lev-
els were noticed during mild and severe poisoning (Figure 2, 
Table 1), indicating O2 displacement from Hb. PaO2 dropped from 
11.1 ± 2.5 kPa at baseline to 4.6 ± 2 kPa during severe CO poisoning 
(P = .0001). No change was noticed in the levels of PaCO2 (P = .67). 
A drop in pH (P = .002) and an increase in lactate (P < .000001) lev-
els were observed in samples obtained during CO exposure, signi-
fying the presence of metabolic acidosis. Glucose exhibited large 
F I G U R E  2   Carboxyhaemoglobin (COHb), oxyhaemoglobin (OHb), lactate and glucose values throughout the experiments. Individual 
measurements are represented by scores in each box- plot indicating samples collected before exposure to CO (baseline; red) to mild (green) 
and severe poisoning (blue). Box- plots explanation: data range (— ), box (interquartile range), median (- ) and individual samples (●)
F I G U R E  3   The effect of CO poisoning on metabolites. A, Overlap of mean spectra profiles from the aliphatic region showing differences 
between intensities of selected metabolites in samples collected before (red) and during severe poisoning (dark blue). Confirmation of CO 
poisoning in the Danish Landrace pig model (n = 11) by increased carboxyhaemoglobin (COHb) and decreased oxyhaemoglobin (OHb) 
levels. B, Data quality was checked by regressing full blood glucose and lactate values recorded on arterial blood gas analyser and serum 
glucose and lactate values recorded by NMR. The coefficient of determination R- square shows a high degree of interrelation between 
these measurements, with R2>.97. The 95% confidence intervals are shown. C, Unsupervised principal component analysis indicates shifts 
in blood metabolites as a consequence of increased CO. The measurements for each pig are shown to emphasize individual changes. There 
are two missing values, one baseline (pig no.6) and one after mild poisoning (pig no.8). D, Group mean metabolite changes as a consequence 
of exposure to CO. E, Metabolite correlations with COHb were calculated by means of Pearson's correlation analysis on log- transformed 
data. A positive correlation indicates increases in metabolite levels, while a negative correlation indicates decreasing metabolite levels with 
increasing COHb
     |  5195SIMONSEN Et al.
5196  |     SIMONSEN Et al.
individual variations, especially under severe poisoning, but these 
changes were not statistically significant (P = .93). In combination, 
increased COHb levels, low blood oxygenation and metabolic acido-
sis confirmed that poisoning was successful.
3.2 | The impact of CO poisoning on blood 
metabolites
Increasing CO levels not only affected lactate and blood gas param-
eters, but also the composition of circulating metabolites. As depicted 
in Figure 3A, several metabolite intensities changed upon poisoning. 
Lactate, alanine, succinate, pyruvate and glycerol signals increased, 
while acetate decreased, with lactate undergoing the most significant 
alterations.
Because lactate and glucose were measured by both arterial 
blood gas analyser (ABL) and NMR techniques, metabolomics data 
quality was assessed by correlating fresh blood lactate and glucose 
measurements recorded on the ABG to serum lactate and glucose 
measured by NMR spectroscopy. High degrees of correlation were 
found (coefficient of determination R- square, R2 = .98; Figure 3B), 
indicating high data quality.
Unsupervised pattern recognition analysis discerned between 
samples collected before and during exposure to CO, as well as be-
tween the degrees of poisoning (Figure 3C). While mild poisoning 
seemed to affect blood metabolites to a lesser extent, as reflected 
by the close proximity of baseline and mild samples, abnormally 
high COHb levels induced significant alterations, indicated by sam-
ples clustering separately along the first principal component (PC1). 
The most significant metabolite changes observed are presented 
in Table 2 and Figure 3D. Lactate, pyruvate, acetoin, aromatic 
amino acids (tyrosine and phenylalanine), purines (xanthine, hypox-
anthine, adenosine and guanosine), tricarboxylic acid (TCA) cycle 
metabolites (citrate, oxoglutarate or 2- ketoglutaric acid, succinate 
TA B L E  2   Serum metabolite changes from baseline through the mild and severe CO poisoning
Baseline 
(mmol/L) Mild (mmol/L) Severe (mmol/L)
Baseline vs mild vs 
severea
Baseline vs 
mildb Baseline vs severeb
Mean SD Mean SD Mean SD Sig. FC Sig. FC Sig.
Lactate 1.39 0.38 1.97 0.88 6.07 1.27 0.000000000004 1.4 0.045 4.4 0.000000005
Pyruvate 0.05 0.01 0.05 0.01 0.23 0.12 0.000000000007 1.1 0.84 5.0 0.000000005
Acetoin 0.16 0.02 0.18 0.03 0.26 0.03 0.000000005 1.1 0.17 1.7 0.00000001
Fumarate 0.003 0.002 0.004 0.002 0.014 0.004 0.000000005 1.1 0.81 4.2 0.00000003
Hypoxanthine 0.07 0.01 0.08 0.02 0.16 0.05 0.00000002 1.2 0.53 2.4 0.00000006
Adenosine 0.012 0.003 0.013 0.003 0.027 0.011 0.00002 1.1 0.89 2.2 0.00005
Choline 0.11 0.02 0.13 0.03 0.18 0.05 0.0002 1.1 0.38 1.6 0.0002
Succinate 0.12 0.04 0.14 0.05 0.23 0.08 0.0003 1.2 0.45 1.9 0.0003
Formate 0.04 0.02 0.04 0.02 0.07 0.02 0.0008 1.1 0.74 1.8 0.001
Acetate 0.32 0.08 0.26 0.05 0.21 0.05 0.003 0.8 0.15 0.7 0.002
Glycerol 0.74 0.11 0.78 0.14 0.96 0.17 0.002 1.0 0.81 1.3 0.003
GPC 0.37 0.06 0.43 0.11 0.57 0.17 0.005 1.2 0.64 1.5 0.005
Citrate 0.16 0.02 0.17 0.03 0.21 0.04 0.008 1.1 0.55 1.3 0.007
Uridine 0.015 0.006 0.019 0.011 0.033 0.013 0.006 1.2 0.87 2.2 0.008
Glyceraldehyde 0.21 0.02 0.22 0.03 0.25 0.03 0.01 1.1 0.59 1.2 0.01
3- HBA 0.33 0.05 0.35 0.04 0.40 0.05 0.02 1.1 0.44 1.2 0.01
Phenylalanine 0.37 0.07 0.42 0.09 0.48 0.09 0.02 1.1 0.34 1.3 0.01
Oxoglutarate 0.05 0.01 0.05 0.01 0.06 0.01 0.03 1.1 0.47 1.2 0.02
Glutathione 0.07 0.01 0.08 0.01 0.09 0.02 0.04 1.1 0.21 1.2 0.03
Alanine 1.21 0.30 1.27 0.37 1.65 0.45 0.03 1.0 0.96 1.4 0.05
AMP, IMP 0.003 0.001 0.002 0.001 0.004 0.001 0.01 0.8 0.82 1.5 0.05
Tyrosine 0.32 0.08 0.36 0.11 0.41 0.09 0.06 1.1 0.56 1.3 0.05
Xanthine 0.045 0.011 0.046 0.015 0.057 0.014 0.09 1.0 0.99 1.3 0.12
Glucose 4.58 1.54 4.85 2.09 5.60 5.29 0.84 1.1 0.99 1.2 0.90
Note: Significance was assessed by means of ANOVA (a) with Tukey' post hoc test for multiple testing (b). A P- value P ≤ .05 was considered statistically 
significant.
Abbreviations: 3- HBA, 3- hydroxybutyric acid; AMP, IMP, adenosine and inosine monophosphate; GPC, glycerophosphocholine; SD, standard 
deviation.
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and fumarate), glutathione, phospholipids and glycerol were ele-
vated, while acetate decreased with increasing blood COHb levels. 
Lactate, pyruvate, acetoin and fumarate were found to strongly cor-
relate with COHb (Pearson correlation coefficient r ≥ .73, P < .0001, 
Figure 3E, Table 3), indicating a possible link between the degree 
of CO intoxication and derangements in the mechanisms involving 
these metabolites. One possible interpretation of altered reactions 
is provided in Figure 4.
4  | DISCUSSION
To our knowledge, this is the first study to investigate metabolite 
responses during the progression of CO poisoning. We found that 
arterial blood gas parameters and several metabolites implicated in 
the regulation of metabolic acidosis, energy synthesis, respiration, 
antioxidant- oxidant balance and lipid metabolism were altered, es-
pecially during severe CO poisoning.
Metabolites are the end products of gene, transcript and 
protein regulation, being strongly influenced by disease pro-
gression,20,24 treatment interventions19,22,23 and environmental 
changes, including CO poisoning.17,18 Therefore, the metabolite 
changes observed in this study reflect a molecular window of 
events occurring during exposure to exogenous CO. Although the 
study investigated changes in pigs, this animal model has similar 
physiological regulatory systems to all mammalian species, includ-
ing brain and muscle oxygen storage and utilization, nitric oxide 
cell signalling, energy metabolism and mitochondrial respiration, 
steroid and drug metabolism, cellular redox balance and ROS.28 
It is expected that some of the various modes of action differ 
quantitatively across species, and that some differences in dose- 
response relationships between humans and animal models can 
be encountered because of differences in CO uptake/elimination 
and binding kinetics with haeme proteins.29 Nevertheless, results 
from this study can be relevant to understanding the mechanisms 
of action of toxic levels of CO and therefore help improve the un-
derstanding of molecular alterations in patients arriving at hospital 
with acute CO poisoning.
Our results indicate that exposure to CO for approximately half 
an hour induced mild acute poisoning, demonstrated by a 28.4% 
mean drop in percentage of O2 bound to Hb, from 91.2 ± 4.9% to 
62.8 ± 7.9%, and a 12- fold increased CO bound to Hb, from 2.9 ± 0.5% 
to 35.2 ± 7.9%. On the other hand, when analysing metabolites, mild 
poisoning had a minor impact, since most metabolites related to hy-
poxia (lactate, P = .25), energy and nutrient balance (acetate, P = .15), 
lipid peroxidation (acetoin, P = .17) and antioxidant- oxidant defence 
(glutathione, P = .21) showed statistically insignificant variation. 
In comparison, at severe poisoning a 65% mean decrease in OHb 
and a 24- fold elevated COHb were observed. Significant changes 
were also observed in the levels of metabolites linked to hypoxia 
(lactate, P < .0001), energy balance (pyruvate, P < .0001; adenosine 
and inosine monophosphate [AMP, IMP], P = .05; acetate, P = .002; 
and 3- hydroxybutyrc acid, P = .01), TCA cycle (citrate, P = .007; suc-
cinate, P = .0003; oxoglutarate, P = .02; and fumarate, P < .0001), 
lipid metabolism (glycerol, P = .002; choline, P = .0002), antioxidant- 
oxidant balance (glutathione, P = .03; adenosine, P < .0001; uridine, 
P = .008; and hypoxanthine, P < .0001) and other amino acids (phe-
nylalanine, P = .01; tyrosine, P = .05).
Glucose, the key glycolytic metabolite involved in the synthe-
sis of cellular energy, exhibited large, but statistically insignificant 
variation during mild and severe poisoning, compared to baseline 
levels. In 1985, Sokal and Kral Kowska30 demonstrated that glucose 
is neither dependent on the length of exposure to CO or severity of 
acute intoxication; hence, our results are in line with the literature. 
In contrast, metabolites downstream of glycolysis including glycer-
aldehyde, pyruvate, alanine and lactate were affected. Increased 
lactate levels with concomitant decreases in blood O2 and in-
creases in COHb levels correspond with metabolic acidosis, a well- 
known mechanism occurring during hypoxia caused by poisoning.31 
Lactate has previously been found to correlate to the degree of CO 
poisoning1 and has been used as a marker of severe poisoning.30 In 
this study, we also observed a high correlation between lactate and 
blood COHb. Hence, our results indicate successful experimental 
CO intoxication, giving confidence to our findings. In addition to 





















AMP, IMP 0.379 .04
Oxoglutarate 0.379 .04
Note: The degree of significance was assessed by applying Pearson' 
correlation analysis on COHb and metabolite data. A high correlation 
and low two- tailed P- value (P ≤ .05) was considered statistically 
significant.
Abbreviations: 3- HBA, 3- hydroxybutyric acid; AMP, IMP, adenosine and 
inosine monophosphate; GPC, glycerophosphocholine.
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the glycolytic metabolites, AMP, IMP, ketones and TCA cycle me-
tabolites were also affected, especially at severe CO poisoning, 
suggesting a derangement in overall energy metabolism beyond 
glycolysis.
In a study investigating the effect of CO on the respiratory 
chain, Miro et al32 found that mitochondrial cytochrome C- oxidase 
was inhibited because of CO- induced hypoxia. Moreover, it is well 
known that inhibition of the respiratory chain invokes mechanisms 
within the TCA cycle that slow ATP turnover and ROS accumu-
lation.33 While we did not measure mitochondrial enzymes, the 
changes in metabolite end products of mitochondrial enzymatic 
activity complement the evidence mentioned above. We observed 
a steep increase in the levels of TCA cycle metabolites, especially 
during severe poisoning, including citrate, 2- ketoglutarate, succi-
nate and fumarate. To our knowledge, only one metabolomics study 
has previously demonstrated increases in blood succinate levels 
from deceased individuals caused by CO intoxication.17 While our 
study confirms alterations in the level of succinate, it also adds 
new molecular insights to the current literature. The same study 
further identified elevated levels of fatty acid, including myristic, 
palmitic, heptadecanoic, stearic, arachidonic and phosphoric acids 
in all deceased individuals.17 According to Ledoux et al,34 increases 
in blood fatty acids content are expected because of the inability 
of hypoxic tissue to support fatty acid beta- oxidation. While we 
were unable to measure these fatty acids with NMR spectroscopy, 
we detected elevated cell membrane- derived glycerol, choline and 
glycerophosphocholine in samples collected during poisoning. 
Moreover, we also found acetoin to be elevated, especially during 
severe poisoning, indicating a possible peroxidation of cell mem-
branes. While lipid peroxidation is expected during CO toxicity, 
no study has previously identified these metabolites. In addition 
to lipid peroxidation, exogenous CO is known to aggravate ROS 
formation and promote cellular damages. Current research shows 
that during CO poisoning, xanthine oxidase and dehydrogenase are 
involved in processes that produce peroxides and superoxides.16 
While we did not measure xanthine oxidase and dehydrogenase, 
their metabolite substrates, hypoxanthine and xanthine, were 
significantly altered during severe toxicity. Lastly, the antioxidant 
metabolite glutathione, involved in ROS balance, was significantly 
elevated during mild and severe poisoning, indicating derange-
ments in oxidant- antioxidant balance.
There are several limitations to our study, including the relatively 
low number of animals enrolled, the lack of a control group and of 
an independent validation study to confirm the observed molecu-
lar alterations. However, we have chosen to show each individual 
pig's metabolite profile to emphasize that the CO- related changes 
are uniform throughout the samples. Moreover, because each pig 
functioned as its own control, the potentially individual variation that 
otherwise may add confounding to the data has been reduced. In ad-
dition, it is always challenging to translate findings from animal stud-
ies to human conditions; however, pigs are similar in physiology and 
anatomy to humans, and hence the results can more easily be trans-
lated to a human setting.26 Moreover, to the best of our knowledge, 
this study is the first metabolomics study of severe CO poisoning in a 
large animal model. We examined metabolites solely on samples ob-
tained until severe heart failure. Measuring changes during recovery 
from poisoning would have provided additional information about 
the mechanisms involved during CO removal from metabolism. This 
must be a focal point in future studies, during which different treat-
ment modalities and their effects on the return to normal conditions 
could also be tested. The treatment of both mild and severe CO poi-
soning has not evolved greatly during the last decades and still con-
sists of oxygen therapy, which in severe cases can be administered 
in a hyperbaric pressure35 chamber. There is ongoing debate about 
whether oxygen therapy reduces the risk of developing neurological 
sequelae or mortality8– 11 or whether it might even be harmful, be-
cause of barotrauma, pulmonary oedema, seizures and free radical 
generation.1,10 Therefore, there is still a need to understand the mo-
lecular basis of current treatments, which may combat the toxic ef-
fects of CO binding to haemoglobin, but fail to counteract the direct 
cellular actions of CO. In future studies, it would be interesting to 
explore the metabolic changes during a slightly less severe poisoning 
for a longer duration of time, including changes related to ongoing 
treatments until restoration of metabolite balance occurs.
5  | CONCLUSION
Our experimental study adds new insights to the deranged metabo-
lite mechanism of CO poisoning, including hypoxia, ROS formation 
and peroxidation. This study leads the way for further studies in-
vestigating this area. Ideally, studies looking into the effects of 
hyperbaric oxygen therapy versus normobaric oxygen should be 
considered. With further research, it may be possible to pinpoint 
markers that can be used to guide the intensity of oxygen therapy 
and thereby diminish some of the harmful side effects of oxygen 
therapy.
ACKNOWLEDG EMENTS
This research received funding from the Research fund of Department 
of Cardiothoracic Surgery at Aalborg University Hospital and 
Brødrene Hartmanns and The Obel Family Foundations. The NMR 
laboratory at Aalborg University is supported by The Obel Family, 
Spar Nord and Carlsberg Foundations.
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